BRAFV600E FRO cells treated with BRAF inhibitor (vemurafenib) for 4, 15, 24 h

ABSTRACT: to identify genes and/or pathways modulated in responce to BRAFinhibitor treatment and likely responsible to drug resistance in thyroid carcinoma cells.

ORGANISM(S): Homo sapiens

SUBMITTER: Giovanni Calice 

PROVIDER: E-MTAB-6799 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress